Medite Cancer Diagnostics, Inc. MDIT
Finances
| 2017 | 2016 | 2015 | |
|---|---|---|---|
| Revenue | 6.813 M -26.25 % | 9.238 M -6.56 % | 9.887 M |
| Net income | -6.811 M -214.89 % | -2.163 M -151.80 % | -859.000 K |
| Income before tax | -7.298 M -218.00 % | -2.295 M -193.85 % | -781.000 K |
| Income before tax ratio | -1.07 -331.18 % | -0.25 -214.50 % | -0.08 |
| EBITDA | -6.187 M -327.57 % | -1.447 M -242.89 % | -422.000 K |
| Net income ratio | -1.00 -326.97 % | -0.23 -169.49 % | -0.09 |
| Ratio EBITDA | -0.91 -479.76 % | -0.16 -266.98 % | -0.04 |
| Gross profit ratio | -0.02 -105.20 % | 0.37 0.83 % | 0.37 |
| Weighted average shs out dil | 26.436 M 23.40 % | 21.424 M 6.08 % | 20.195 M |
| Weighted average shs out | 26.436 M 23.40 % | 21.424 M 6.08 % | 20.195 M |
| EPS diluted | -0.26 -160.00 % | -0.10 -135.29 % | -0.04 |
| Earnings per share | -0.26 -160.00 % | -0.10 -135.29 % | -0.04 |
| Gross profit | -131.000 K -103.83 % | 3.416 M -5.79 % | 3.626 M |
| Income tax expense | -487.000 K -268.94 % | -132.000 K -269.23 % | 78.000 K |
| Cost of revenue | 6.944 M 19.27 % | 5.822 M -7.01 % | 6.261 M |
| General and administrative expenses | 0.000 | 0.000 | 0.000 |
| Selling and marketing expenses | 0.000 | 0.000 | 0.000 |
| Other expenses | 0.000 | 0.000 | 0.000 |
| Operating expenses | 6.349 M 25.05 % | 5.077 M 20.17 % | 4.225 M |
| Cost and expenses | 13.293 M 21.97 % | 10.899 M 3.94 % | 10.486 M |
| Research and development expenses | 1.188 M -19.57 % | 1.477 M 15.57 % | 1.278 M |
| Selling general and administrative expenses | 5.161 M 43.36 % | 3.600 M 22.16 % | 2.947 M |
| Interest income | 0.000 | 0.000 | 0.000 |
| Interest expense | 849.000 K 22.33 % | 694.000 K 240.20 % | 204.000 K |
| Depreciation and amortization | 293.000 K 36.92 % | 214.000 K 20.90 % | 177.000 K |
| Operating income | -6.480 M -290.13 % | -1.661 M -177.30 % | -599.000 K |
| Operating income ratio | -0.95 -428.99 % | -0.18 -196.78 % | -0.06 |
| Total other income expenses net | -818.000 K -29.02 % | -634.000 K -248.35 % | -182.000 K |
| 2017 | 2016 | 2015 |
| 2017 | 2016 | 2015 | |
|---|---|---|---|
| Net debt | 4.904 M 23.16 % | 3.982 M 17.53 % | 3.388 M |
| Total investments | 0.000 100.00 % | -25.000 K | 0.000 |
| Total debt | 5.394 M 31.89 % | 4.090 M 2.89 % | 3.975 M |
| Accumulated other comprehensive income loss | -444.000 K 30.84 % | -642.000 K -107.99 % | 8.034 M |
| Retained earnings | -8.195 M -492.12 % | -1.384 M -277.66 % | 779.000 K |
| Common stock | 29.000 K 26.09 % | 23.000 K 9.52 % | 21.000 K |
| Total equity | 5.775 M -27.79 % | 7.998 M -12.74 % | 9.166 M |
| Other non current liabilities | 0.000 | 0.000 | 0.000 |
| Long term debt | 4.914 M 2 420.00 % | 195.000 K -76.95 % | 846.000 K |
| Total non current liabilities | 6.399 M 190.86 % | 2.200 M -27.89 % | 3.051 M |
| Other current liabilities | 2.402 M 3.31 % | 2.325 M -2.31 % | 2.380 M |
| Deferred revenue | 0.000 | 0.000 | 0.000 |
| Short term debt | 376.000 K -90.35 % | 3.895 M 24.48 % | 3.129 M |
| Total current liabilities | 3.782 M -48.52 % | 7.347 M 19.25 % | 6.161 M |
| Total liabilities | 10.181 M 6.64 % | 9.547 M 3.64 % | 9.212 M |
| Other non current assets | -4.462 M -3 054.97 % | 151.000 K 103.44 % | -4.385 M |
| Long term investments | 0.000 100.00 % | -25.000 K | 0.000 |
| Intangible assets | 10.518 M 0.00 % | 10.518 M 0.00 % | 10.518 M |
| GoodWill | 4.658 M 0.00 % | 4.658 M 0.00 % | 4.658 M |
| Goodwill and intangible assets | 15.176 M 0.00 % | 15.176 M 0.00 % | 15.176 M |
| Property plant equipment net | 1.778 M 14.19 % | 1.557 M -19.78 % | 1.941 M |
| Total non current assets | 12.492 M 2.39 % | 12.201 M -4.17 % | 12.732 M |
| Other current assets | 535.000 K 577.22 % | 79.000 K -57.53 % | 186.000 K |
| Short term investments | 0.000 | 0.000 | 0.000 |
| cash and cash equivalents | 490.000 K 353.70 % | 108.000 K -81.60 % | 587.000 K |
| Cash and short term investments | 490.000 K 353.70 % | 108.000 K -81.60 % | 587.000 K |
| Total current assets | 3.464 M -35.18 % | 5.344 M -5.35 % | 5.646 M |
| Inventory | 2.403 M -36.95 % | 3.811 M 23.93 % | 3.075 M |
| Net receivables | 453.000 K -66.34 % | 1.346 M -25.14 % | 1.798 M |
| Tax assets | 0.000 100.00 % | -4.658 M | 0.000 |
| Other assets | 0.000 | 0.000 | 0.000 |
| Account payables | 1.004 M -10.91 % | 1.127 M 72.85 % | 652.000 K |
| Tax payables | 0.000 | 0.000 | 0.000 |
| Deferred revenue non current | -1.000 | 0.000 | 0.000 |
| Minority interest | 0.000 | 0.000 | 0.000 |
| Capital lease obligations | 0.000 | 0.000 | 0.000 |
| Preferred stock | 962.000 K 0.00 % | 962.000 K 0.00 % | 962.000 K |
| Other total stockholders equity | 13.423 M 48.50 % | 9.039 M 12.80 % | 8.013 M |
| Deferred tax liabilities non current | 1.485 M -25.94 % | 2.005 M -9.07 % | 2.205 M |
| Other liabilities | 0.000 | 0.000 | 0.000 |
| Total assets | 15.956 M -9.06 % | 17.545 M -4.53 % | 18.378 M |
| 2017 | 2016 | 2015 |
| 2017 | 2016 | 2015 | |
|---|---|---|---|
| Deferred income tax | 492.000 K | 0.000 -100.00 % | 78.000 K |
| Stock based compensation | 0.000 | 0.000 | 0.000 |
| Change in working capital | 1.888 M 1 363.57 % | 129.000 K -40.28 % | 216.000 K |
| Accounts receivables | 589.000 K 87.58 % | 314.000 K 62.69 % | 193.000 K |
| Inventory | 1.434 M 270.51 % | -841.000 K -347.35 % | 340.000 K |
| Accounts payables | -75.000 K -113.46 % | 557.000 K 295.44 % | -285.000 K |
| Other working capital | -60.000 K -160.61 % | 99.000 K 409.38 % | -32.000 K |
| Other non cash items | 191.000 K -83.05 % | 1.127 M | 0.000 |
| Net cash provided by operating activities | -2.585 M -136.94 % | -1.091 M -181.19 % | -388.000 K |
| Investments in property plant and equipment | -134.000 K -16.52 % | -115.000 K 67.51 % | -354.000 K |
| Acquisitions net | 0.000 | 0.000 | 0.000 |
| Purchases of investments | 0.000 | 0.000 | 0.000 |
| Sales maturities of investments | 0.000 | 0.000 | 0.000 |
| Other investing activites | 0.000 | 0.000 | 0.000 |
| Net cash used for investing activites | -134.000 K -16.52 % | -115.000 K 67.51 % | -354.000 K |
| Debt repayment | 1.543 M 624.41 % | 213.000 K 170.53 % | -302.000 K |
| Common stock issued | 2.344 M 515.22 % | 381.000 K -81.45 % | 2.054 M |
| Common stock repurchased | 0.000 | 0.000 | 0.000 |
| Dividends paid | 0.000 | 0.000 | 0.000 |
| Other financing activites | -422.000 K -498.11 % | 106.000 K 365.00 % | -40.000 K |
| Net cash used provided by financing activities | 3.882 M 454.57 % | 700.000 K -59.11 % | 1.712 M |
| Effect of forex changes on cash | 0.000 | 0.000 | 0.000 |
| Net change in cash | 382.000 K 175.49 % | -506.000 K -152.16 % | 970.000 K |
| Cash at beginning of period | 108.000 K -82.41 % | 614.000 K | 0.000 |
| Cash at end of period | 490.000 K 353.70 % | 108.000 K -88.87 % | 970.000 K |
| Operating cash flow | -2.585 M -136.94 % | -1.091 M -181.19 % | -388.000 K |
| Capital expenditure | -134.000 K -16.52 % | -115.000 K 67.51 % | -354.000 K |
| Free CashFlow | -2.719 M -125.46 % | -1.206 M -62.53 % | -742.000 K |
| 2017 | 2016 | 2015 |
| Revenue |
| Net income |
| Income before tax |
| Income before tax ratio |
| EBITDA |
| Net income ratio |
| Ratio EBITDA |
| Gross profit ratio |
| Weighted average shs out dil |
| Weighted average shs out |
| EPS diluted |
| Earnings per share |
| Gross profit |
| Income tax expense |
| Cost of revenue |
| General and administrative expenses |
| Selling and marketing expenses |
| Other expenses |
| Operating expenses |
| Cost and expenses |
| Research and development expenses |
| Selling general and administrative expenses |
| Interest income |
| Interest expense |
| Depreciation and amortization |
| Operating income |
| Operating income ratio |
| Total other income expenses net |
| Net debt |
| Total investments |
| Total debt |
| Accumulated other comprehensive income loss |
| Retained earnings |
| Common stock |
| Total equity |
| Other non current liabilities |
| Long term debt |
| Total non current liabilities |
| Other current liabilities |
| Deferred revenue |
| Short term debt |
| Total current liabilities |
| Total liabilities |
| Other non current assets |
| Long term investments |
| Intangible assets |
| GoodWill |
| Goodwill and intangible assets |
| Property plant equipment net |
| Total non current assets |
| Other current assets |
| Short term investments |
| cash and cash equivalents |
| Cash and short term investments |
| Total current assets |
| Inventory |
| Net receivables |
| Tax assets |
| Other assets |
| Account payables |
| Tax payables |
| Deferred revenue non current |
| Minority interest |
| Capital lease obligations |
| Preferred stock |
| Other total stockholders equity |
| Deferred tax liabilities non current |
| Other liabilities |
| Total assets |
| Deferred income tax |
| Stock based compensation |
| Change in working capital |
| Accounts receivables |
| Inventory |
| Accounts payables |
| Other working capital |
| Other non cash items |
| Net cash provided by operating activities |
| Investments in property plant and equipment |
| Acquisitions net |
| Purchases of investments |
| Sales maturities of investments |
| Other investing activites |
| Net cash used for investing activites |
| Debt repayment |
| Common stock issued |
| Common stock repurchased |
| Dividends paid |
| Other financing activites |
| Net cash used provided by financing activities |
| Effect of forex changes on cash |
| Net change in cash |
| Cash at beginning of period |
| Cash at end of period |
| Operating cash flow |
| Capital expenditure |
| Free CashFlow |